Search clinical trials for: Regorafenib Oral Product

Total 10934 results

Fudan University

Recruiting

Regorafenib Alone or in Combination With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer (SLOT)

Microsatellite Stable Metastatic Colorectal Cancer

China
Yonsei University

Recruiting

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

Melanoma

Korea, Republic of
Boehringer Ingelheim

Completed

A Study in Healthy Men to Find the Best Formulation of BI 685509 and to Test How it is Taken up in the Body

Healthy

United Kingdom
British Columbia Cancer Agency
Bayer

Completed

Phase II Study of Perindopril and Regorafenib in mCRC (PARICCA)

Metastatic Colorectal Cancer

Canada
Institut Bergonié
Bayer; Merck KGaA, Darmstadt, Germany

Recruiting

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)

Hepatocellular Carcinoma | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Soft-tissue Sarcoma | Urothelial Carcinoma | Thyroid Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Biliary Tract Cancer | HPV-Related Carcinoma | Solid Tumor, Adult | Mesotheliomas Pleural | GIST | Renal Carcinoma | Colorectal... and other conditions

France
University of Colorado, Denver
Delta Dental Foundation

Completed

Oral Health Care Early Intervention Project

Caries

United States
Imperial Brands PLC

Active, not recruiting

A Relative Bioavailability Study of Nicotine Delivery From Selected Oral Nicotine Products

Healthy Volunteers

Sweden
RAI Services Company
ICON plc

Completed

CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems

Smoking | Tobacco Use | Tobacco Smoking

United States
Children's Memorial Health Institute, Poland
Medical University of Bialystok; University of Rzeszow

Unknown

Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years.

Constipation

Poland
Abbott Nutrition

Not yet recruiting

Preterm Infants Fed a Human Milk Fortifier

Growth
Novo Nordisk A/S

Completed

Injection Site Pain Comparison of Excipient Solutions

Obesity

Netherlands
The Dermatology Institute of Boston

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis

Perioral Dermatitis

United States
Yale University

Recruiting

Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI

Stroke | Intracranial Atherosclerosis

United States
Copenhagen Studies on Asthma in Childhood

Recruiting

Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms (COPSACazt)

Childhood Asthma With Acute Exacerbation

Denmark
Danone Asia Pacific Holdings Pte, Ltd.
Nutricia Research

Completed

New Infant Formula Trial in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety (Venus)

Healthy

Singapore
Stoffwechselzentrum Rhein - Pfalz
Glucanova AB

Completed

Influence of a Liquid Oat Bran Product on Blood Glucose in Patients With Poorly Controlled Type 2 Diabetes

Obesity | Diabetes Mellitus, Type 2 | Overweight | Metabolic Syndrome

Germany
Beijing YouAn Hospital
Beijing Gene Key Life Technology Co., Ltd.

Recruiting

Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy

Hepatocellular Carcinoma

China
Wake Forest University Health Sciences
Bayer

Completed

A Study of Regorafenib in Advanced Pancreatic Cancer Patients

Pancreatic Cancer

United States
Bayer

Completed

Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib (COLONG)

Colorectal Neoplasms

Belgium
Bayer

Terminated

A Phase 4 Study of Regorafenib in Metastatic Colorectal Cancer - Does Educating Physicians Change Patient Outcomes? (SMART)

Physician Education

United States
Nutricia Research

Recruiting

Glin3: Assessment of the Glycemic Responses to Nutritional Products (GLIN#3)

Glycemic Response

Canada
Danone Research

Completed

Metabolic Response to Beverages With Various Sweetening Systems Consumed During Meal in Overweight and Obese Subjects (AQUAGLU-1)

Overweight and Obesity

France
Imperial Brands PLC

Completed

A Randomised, Cross-over, Relative Bioavailability Study of Nicotine Delivery and Nicotine Extraction From Oral Products

Healthy Volunteers

Sweden
Örebro University, Sweden

Not yet recruiting

Effects of In-between Meal Products on Cognitive Function in Older Adults (Minimeal)

Cognitive Function
Abbott Nutrition

Completed

Food for Special Medical Purpose in Patients With Digestive Tract Tumor

Gastrointestinal Cancer

China
Suzanne George, MD
Massachusetts General Hospital; Fox Chase Cancer Center; Bayer; Brigham and Women... and other collaborators

Completed

Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumor

United States
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Withdrawn

Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment

Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Rectal Adenocarcinoma

United States
Lund University
Vinnova; Öste Venture AB

Completed

Dietary Fibre and Metabolic Benefits

Glucose Tolerance

Sweden
Thomas Jefferson University
Christiana Care Health Services

Completed

Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial (ADAPT)

Preterm Premature Rupture of Membrane

United States
Università degli Studi di Sassari

Completed

Effect of a Self-adhering Material in Dental Hypersensitivity

Dentin Sensitivity | Xerostomia

Italy
Pharmtechnology LLC
Algorithme Pharma, An Altasciences Company

Completed

Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

Bioequivalence

Canada
Universidad Católica San Antonio de Murcia

Completed

Evaluation of the Glycemic Index in 4 Dairy Beverages. (IG)

Glycemic Index | Cognitive Performance

Spain
Pierre Fabre Dermo Cosmetique

Recruiting

Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.

Vitiligo

France
Nutricia Research

Active, not recruiting

Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants. (Renoir)

Growth | Tolerance | Safety | Subjects in Need of a Human Milk Fortifier (HMF)

Netherlands, France, Germany, United Kingdom
Kaohsiung Medical University Chung-Ho Memorial...

Completed

8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

Hepatitis C, Chronic

Taiwan
Second Affiliated Hospital, School of Medicine,...

Recruiting

Study of the Safety and Effectiveness of HIFU Combined With REGOTORI for Metastatic Colorectal Cancer

Colorectal Cancer

China
Case Comprehensive Cancer Center

Active, not recruiting

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Recurrent Glioblastoma

United States
Bayer

Terminated

Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer

Neoplasms

United States
Aventure AB

Completed

Second Meal Effects of a Wholegrain Cereal Product on Blood Glucose Response

Blood Glucose Response

Sweden
University Rovira i Virgili

Completed

Effects of Cocoa Products on Cardiovascular Disease Risk Factors (CoCD)

Cardiovascular Diseases

Spain
GlaxoSmithKline

Completed

A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive

Denture Retention

United States
Universidad Católica San Antonio de Murcia

Completed

Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain (Backin)

Back Pain | Supplementation

Spain
Tianjin Medical University Cancer Institute and...

Recruiting

Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer

Advanced Biliary Tract Cancer

China
Gerald Batist
Bayer; Quebec Clinical Research Organization in Cancer

Unknown

Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers

Metastatic Colorectal Cancer

Canada
OPKO Health, Inc.

Completed

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Vitamin D Insufficiency | CKD Stage 4 | CKD Stage 3 | Secondary Hyperparathyroidism Due to Renal Causes

United States
Ain Shams University

Not yet recruiting

Effect of Ambroxol in Diabetic Peripheral Neuropathy

Diabetic Neuropathy Peripheral

Egypt
University of Nove de Julho
Sandra Kalil Bussadori

Completed

Dose Parameters for Photodynamic Therapy on Periodontal Disease

Chronic Periodontitis
Imperial College London

Not yet recruiting

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

Steroid-Induced Diabetes | Steroid Induced Hyperglycemia

United Kingdom
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Recruiting

Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine (CADENCE)

Cardiovascular Diseases | Inflammation | Diabetes | Atherosclerosis

Canada
Great Novel Therapeutics Biotech & Medicals Corporation

Recruiting

Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC)

Taiwan

Search clinical trials for: Regorafenib Oral Product

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations